Mechanism
Targets the inner mitochondrial membrane to support energy production — under interest for chronic kidney disease.
TechnicalBinds cardiolipin, stabilizes the electron transport chain, reduces ROS production.
Reported uses by species
| Species | Indication | Tier | Honest evidence note |
|---|---|---|---|
| Cats | Chronic kidney disease (early veterinary interest) | Investigational | Evidence emerging; not approved. |
Suggested starting protocol
Starting points only — clinical judgment required. Dosing unlocks for verified veterinary accounts.
No species-specific starting protocol published. Contact clinical support.
Monitoring, contraindications & do-not-use-if
Investigational; no validated veterinary dosing.
The evidence
- CIVT veterinary webinar — mitochondrial peptidesCIVT